Cas no 62458-92-8 (2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One)
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One Chemical and Physical Properties
Names and Identifiers
-
- 2-Amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one
- 2-amino-7-benzyl-1,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one
- CS-0083453
- SCHEMBL15189148
- AKOS022172440
- AM807715
- AS-32317
- 2-amino-7-benzyl-5,6,7,8-tetrahydropyrido-[3,4-d]pyrimidin-4(3H)-one
- 2-Amino-7-benzyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one
- 62458-92-8
- PUDMEXIJNZOGIC-UHFFFAOYSA-N
- 2-amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-ol
- 2-Amino-7-benzyl-5,6,7,8-tetrahydro-1H-pyrido[3,4-d]pyrimidin-4-one
- DTXSID00487034
- 2-amino-7-benzyl-3,5,6,8-tetrahydropyrido[3,4-d]pyrimidin-4-one
- SCHEMBL721339
- 2-Amino-7-benzyl-5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidin-4-ol
- DB-292915
- 2-AMINO-7-BENZYL-3H,5H,6H,8H-PYRIDO[3,4-D]PYRIMIDIN-4-ONE
- 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One
-
- MDL: MFCD24843097
- Inchi: 1S/C14H16N4O/c15-14-16-12-9-18(7-6-11(12)13(19)17-14)8-10-4-2-1-3-5-10/h1-5H,6-9H2,(H3,15,16,17,19)
- InChI Key: PUDMEXIJNZOGIC-UHFFFAOYSA-N
- SMILES: O=C1C2=C(CN(CC3C=CC=CC=3)CC2)N=C(N)N1
Computed Properties
- Exact Mass: 256.13241115g/mol
- Monoisotopic Mass: 256.13241115g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 19
- Rotatable Bond Count: 2
- Complexity: 435
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.1
- Topological Polar Surface Area: 70.7?2
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | A579318-50mg |
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidin-4(3h)-One |
62458-92-8 | 50mg |
$ 50.00 | 2022-06-08 | ||
| TRC | A579318-100mg |
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidin-4(3h)-One |
62458-92-8 | 100mg |
$ 95.00 | 2022-06-08 | ||
| TRC | A579318-500mg |
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidin-4(3h)-One |
62458-92-8 | 500mg |
$ 320.00 | 2022-06-08 | ||
| Chemenu | CM123151-1g |
2-amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one |
62458-92-8 | 95% | 1g |
$*** | 2023-05-30 | |
| Alichem | A029185123-1g |
2-Amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one |
62458-92-8 | 95% | 1g |
$363.12 | 2023-09-01 | |
| Alichem | A029185123-5g |
2-Amino-7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one |
62458-92-8 | 95% | 5g |
$1069.00 | 2023-09-01 | |
| 1PlusChem | 1P00EKSK-1g |
2-AMino-7-benzyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyriMidin-4-one |
62458-92-8 | 98% | 1g |
$295.00 | 2024-04-22 | |
| 1PlusChem | 1P00EKSK-5g |
2-AMino-7-benzyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyriMidin-4-one |
62458-92-8 | 98% | 5g |
$942.00 | 2024-04-22 | |
| 1PlusChem | 1P00EKSK-10g |
2-AMino-7-benzyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyriMidin-4-one |
62458-92-8 | 98% | 10g |
$1585.00 | 2024-04-22 | |
| A2B Chem LLC | AG79332-1g |
2-Amino-7-benzyl-5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidin-4-ol |
62458-92-8 | 98% | 1g |
$236.00 | 2024-04-19 |
2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One Related Literature
-
Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
-
Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
Additional information on 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One
Recent Advances in the Study of 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One (CAS: 62458-92-8)
The compound 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One (CAS: 62458-92-8) has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules and its direct pharmacological effects. This research brief consolidates the latest findings to provide a comprehensive overview of its current status in drug discovery and development.
Recent investigations into the pharmacological properties of 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One have highlighted its potential as a kinase inhibitor. Kinases play a crucial role in various cellular processes, and their dysregulation is implicated in numerous diseases, including cancer and inflammatory disorders. Preliminary in vitro studies indicate that this compound exhibits selective inhibition against specific kinase targets, suggesting its utility in targeted therapy development. Further mechanistic studies are underway to elucidate its binding affinity and selectivity profile.
In addition to its kinase inhibitory activity, 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One has been investigated for its role in modulating cellular signaling pathways. Recent research has demonstrated its ability to influence key pathways such as PI3K/AKT and MAPK, which are critical in cell proliferation and survival. These findings open new avenues for the development of novel therapeutics targeting these pathways, particularly in oncology and autoimmune diseases.
The synthetic accessibility of 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One has also been a focus of recent studies. Advances in synthetic methodologies have enabled the efficient production of this compound with high purity and yield, facilitating its use in both research and potential clinical applications. Researchers have optimized reaction conditions to minimize by-products and improve scalability, addressing previous challenges in its synthesis.
Despite these promising developments, challenges remain in the clinical translation of 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One. Pharmacokinetic studies are needed to assess its bioavailability, metabolic stability, and toxicity profile. Current efforts are focused on structural modifications to enhance its drug-like properties while retaining its biological activity. Collaborative research between academic institutions and pharmaceutical companies is expected to accelerate its progression toward preclinical and clinical evaluation.
In conclusion, 2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One (CAS: 62458-92-8) represents a promising scaffold in medicinal chemistry with diverse therapeutic potential. Ongoing research aims to fully characterize its biological activities and optimize its properties for drug development. The compound's dual role as a kinase inhibitor and modulator of cellular signaling pathways underscores its significance in the pursuit of novel treatments for complex diseases.
62458-92-8 (2-Amino-7-Benzyl-5,6,7,8-Tetrahydropyrido3,4-DPyrimidin-4(3h)-One) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)